Speaker Profile

Ph.D., VP of Americas, Aiforia Inc.

Biography
Dr. Thomas Westerling-Bui received his PhD in cancer biology, focusing on the cell cycle and transcription, from the University of Helsinki Medical School in Finland. He completed a post-doctoral EMBO fellowship at the Dana Farber Cancer Institute in Boston, researching the genomics of breast and prostate cancer. Thomas joined Aiforia to advance the new potential of cancer biology, pathology, big data, and artificial intelligence.


 Session Abstract – PMWC 2023 Silicon Valley


Track 2, January 25

Track Co-Chairs:
Russ Cucina, UCSF

  • How can AI and Data Science Determine Which Patients should be Preemptively Tested? (PANEL)
    Chair: Russ Cucina, UCSF
    - Lisa Kroon, UCSF
  • Establishing Genomics in the Clinic as a Routine Requires AI and Automation
    Chair: Bani Tamraz, UCSF
    - Sergio Baranzini, UCSF
    - Gill Bejeran, Stanford
  • Representation and Equity in Genomic Data
    Chair: Karen Miga, UCSC
    - Timothy Rebbeck, Harvard
    - Keolu Fox, UC San Diego
  • Overcoming Barriers to Bringing Multi-omic's into Clinical Practices
    Chair: Russ Cucina, UCSF
    - Peter DeVault, Epic
    - Kevin Hass, Myriad
    - Kevin Cramer, Sapio Science
  • Misaligned Incentives Across Public-Private Partnerships in Patient Health (PANEL)
    Chair: Justin Wildsmith, Syntropy
    - Ken Harris, AWS
    - Steve Goldstein, UC Irvine
    - Suzanne George, Dana Farber Cancer Institute
    - Nelson D’Antonio, Palantir
  • PMWC Showcase:
    - Thomas Westerling-Bui, Aiforia Inc.